The Role of Arginine Methylation of Hnrnpul1 in the DNA Damage Response Pathway Gayathri Gurunathan

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Arginine Methylation of Hnrnpul1 in the DNA Damage Response Pathway Gayathri Gurunathan The role of arginine methylation of hnRNPUL1 in the DNA damage response pathway Gayathri Gurunathan Faculty of Medicine Division of Experimental Medicine McGill University, Montreal, Quebec, Canada August 2014 A Thesis Submitted to McGill University in Partial Fulfillment of the Requirements for the Degree of Master of Science © Gayathri Gurunathan 2014 Abstract Post-translational modifications play a key role in mediating the DNA damage response (DDR). It is well-known that serine/threonine phosphorylation is a major post-translational modification required for the amplification of the DDR; however, less is known about the role of other modifications, such as arginine methylation. It is known that arginine methylation of the DDR protein, MRE11, by protein arginine methyltransferase 1 (PRMT1) is essential for the response, as the absence of methylation of MRE11 in mice leads to hypersensitivity to DNA damage agents. Herein, we identify hnRNPUL1 as a substrate of PRMT1 and the methylation of hnRNPUL1 is required for DNA damage signalling. I show that several RGG/RG sequences of hnRNPUL1 are methylated in vitro by PRMT1. Recombinant glutathione S-transferase (GST) proteins harboring hnRNPUL1 RGRGRG, RGGRGG and a single RGG were efficient in vitro substrates of PRMT1. Moreover, I performed mass spectrometry analysis of Flag-hnRNPUL1 and identified the same sites methylated in vivo. PRMT1-depletion using RNA interference led to the hypomethylation of hnRNPUL1, consistent with PRMT1 being the only enzyme in vivo to methylate these sequences. We replaced the arginines with lysine in hnRNPUL1 (Flag- hnRNPUL1RK) such that this mutant protein cannot be methylated by PRMT1. Indeed Flag- hnRNPUL1RK was undetected using specific dimethylarginine antibodies. Flag-hnRNPUL1RK did not co-immunoprecipitate with PRMT1, as expected, since PRMT1 is known to associate with its substrates. Flag-hnRNPUL1RK had reduced affinity to NBS1, a subunit of the MRE11- RAD50-NBS1, a DDR complex. Finally, Flag-hnRNPUL1RK had an aberrant localization at DNA damage breaks using laser microirradiation. Collectively, my findings provide insight into how the arginine methylation of hnRNPUL1 plays a significant role in the DNA damage response. 2 Sommaire Les modifications post-traductionnelles jouent un rôle fondamental, notamment dans la régulation des mécanismes de réponse aux dommages causés à l’ADN. Il a été démontré que la méthylation des arginines de la protéine MRE11 par l’enzyme protéine-arginine méthyltransférase 1 (PRMT1) est essentiel dans la voie de signalisation des dommages causés à l’ADN. Dans cette étude, nous décrivons l’identification d’un nouveau substrat de l’enzyme PRMT1 : la protéine hnRNPUL1. Dans un premier temps, nous avons identifié que la déplétion de l’enzyme PRMT1 induit une hypométhylation de la protéine hnRNPUL1. De plus la protéine hnRNPUL1 contient plusieurs motifs RGG/RG, une séquence consensus méthylée par les PRMTs. Un essai de méthylation in vitro a montré que plusieurs de ces séquences consensus sont méthylées par l’enzyme PRMT1. Une analyse in vivo de la protéine Flag-hnRNPUL1 par spectrométrie de masse a confirmée les sites de méthylation des motif RGG/RG identifiés précédemment in vitro. Ces résultats furent supportés par la génération d’un mutant Flag-hnRNPUL1RK dépourvue d’arginine dans les séquences RGG/RG méthylées identifiées. En utilisant un anticorps spécifique reconnaissant les arginines diméthylées, nous avons découvert que le mutant Flag- hnRNPUL1RK était hypométhylé. Nous avons également observé que le mutant ne pouvait plus interagir avec PRMT1 par co-immunoprécipitation, contrairement à la protéine non-muté Flag- hnRNPUL1. Ensemble ces résultats démontrent une association physique de la protéine hnRNPUL1 avec PRMT1 requise pour sa méthylation directe par PRMT1 sur les résidus arginines de ces motifs RGG/RG. 3 Nous avons ensuite découvert que le mutant hypométhylé Flag-hnRNPUL1RK présente une affinité de liaison réduite avec la sous-unité NBS1 du complexe de recrutement MRE11- RAD50-NBS1(MRN), impliqué dans la réponse aux dommages à l’ADN. En effet, nous avons été capable de co-immunoprécipiter la sous-unité NBS1 avec la protéine Flag-hnRNPUL1, mais pas avec son mutant Flag-hnRNPUL1RK. Finalement, la localisation de Flag-hnRNPUL1RK est aberrante en présence aux coupures des brins d’ADN. Nous pensons que ce mécanisme est régulé par la méthylation des motifs RGG/RG de hnRNPUL1 par PRMT1. De façon globale, ces résultats illustrent la façon dont la méthylation des arginines de la protéine hnRNPUL1 par l’enzyme PRMT1 joue un rôle de premier plan au niveau de la réponse aux dommages de l’ADN produite par les coupures doubles brins. 4 Preface This Master of Science thesis was written in accordance with the Guidelines for Thesis Preparation from the Faculty of Graduate Studies and Research of McGill University. The experiments and studies were conducted under the supervision of Dr.Stéphane Richard. As well, each contributor who has collaborated in this research is acknowledged in the following section and throughout the remainder of the text. The mass spectrometry analysis discussed in this thesis was performed by Dr. Éric Bonneil (Figure 6B). The laser scissor damage experiment discussed in this thesis was performed by Yan Coulombe in Dr. Jean-Yves Masson laboratory (Université de Laval) (Figure 9A). 5 Acknowledgements I would first like to extend my sincere gratitude and appreciation to my supervisor, Dr. Stéphane Richard, for giving me the remarkable opportunity to work on such an interesting project and guiding me every step of the way. His continuous support and encouragement has truly been the propelling force that has motivated and inspired me to learn various technical skills and explore the field without limiting myself, thereby allowing me to grow as a young scientist and pursue my studies at McGill University in an active and dynamic environment. I would also like to thank the members of my thesis advisory committee, who have provided me with valuable guidance and support while monitoring my progress throughout my studies. Their input and feedback throughout my annual committee meetings have been truly noteworthy and have enabled me to push myself a step higher in pursuing my scientific goals while constantly driving myself forward. My fellow colleagues (both past and present) in the Richard lab have provided me with immense support, guidance and care, which I am truly grateful for. Whether it is moral support during times of need, experimental expertise when troubleshooting experiments, or simply providing a friendly and exciting atmosphere to work in on a daily basis, I truly appreciate their support. I would like to extend my special thanks and sincere gratitude to Dr. Zhenbao Yu, who has provided me with continuous support in helping me develop the necessary skills required to perform various experiments and for his valuable input in the troubleshooting aspect of my experimental techniques. His guidance and experimental expertise has made a significant contribution to my project and allowed for the completion of my thesis. As well, my utmost gratitude goes out to Palaniraja Thandapani who has been extremely supportive in the 6 stimulation of scientific discussions and in providing moral support. All of my dear lab members have been the constant driving force in improving my research strategies in all aspects and their immense care, generosity and unconditional support has truly allowed me to acquire various skills and values both inside and outside the professional environment which are tools that shall be useful throughout my life. I also like to extend my thanks to the all the students, technicians and post-doctoral fellows who I have met at the Lady Davis Institute throughout my studies, for their insight into my project, moral support and encouragement. I would like to extend my gratitude to Dr. Éric Bonneil for performing the mass spectrometry analysis which has significantly contributed to my project. As well, the laser scissor damage research provided by Yan Coulombe under the guidance of Dr. Jean-Yves Masson has been crucial for the completion of my thesis and I would like to sincerely thank them for their valuable contribution to my project. I would like to acknowledge the Canadian Institutes of Health Canada (CIHR) for providing financial support for the research presented in this thesis. Last but not least, I would like to thank my parents and brother for being there for me and supporting me throughout my graduate studies and schooling. I am forever grateful for the love and care that they have provided me with. Their continuous support and motivation have always encouraged me to chase my dreams in life. 7 Table of Contents ABSTRACT ............................................................................................................2 SOMMAIRE ...........................................................................................................3 PREFACE ...............................................................................................................5 ACKNOWLEDGEMENTS ..................................................................................6 TABLE OF CONTENTS .......................................................................................8 LIST OF FIGURES AND TABLES ...................................................................10 LIST OF ABBREVIATIONS .............................................................................. 11 INTRODUCTION................................................................................................15
Recommended publications
  • Behavioural Brain Research 217 (2011) 271–281
    Behavioural Brain Research 217 (2011) 271–281 Contents lists available at ScienceDirect Behavioural Brain Research journal homepage: www.elsevier.com/locate/bbr Research report The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome Arnaud Duchon a, Stéphanie Pothion b, Véronique Brault a, Andrew J. Sharp c, Victor L.J. Tybulewicz d, Elizabeth M.C. Fisher e, Yann Herault a,b,f,∗ a Institut de Génétique Biologie Moléculaire et Cellulaire, Translational Medicine and Neuroscience Program, IGBMC, CNRS, INSERM, Université de Strasbourg, UMR7104, UMR964, 1 rue Laurent Fries, 67404 Illkirch, France b Transgenese et Archivage Animaux Modèles, TAAM, CNRS, UPS44, 3B rue de la Férollerie 45071 Orléans, France c Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, 1425 Madison Avenue, Room 14-75B, Box 1498, New York, NY 10029, USA d MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK e UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK f Institut Clinique de la Souris, ICS, 1 rue Laurent Fries, 67404 Illkirch, France article info abstract Article history: Trisomy 21 or Down syndrome (DS) is the most common form of human aneuploid disorder. Increase Received 5 September 2010 in the copy number of human chromosome 21 genes leads to several alterations including mental retar- Received in revised form 6 October 2010 dation, heart and skeletal dysmorphologies with additional physiological defects. To better understand Accepted 17 October 2010 the genotype and phenotype relationships, several mouse models have been developed, including the Available online 31 October 2010 transchromosomic Tc1 mouse, which carries an almost complete human chromosome 21, that displays several locomotor and cognitive alterations related to DS.
    [Show full text]
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
    [Show full text]
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • Epigenetic Arginine Methylation in Breast Cancer: Emerging Therapeutic Strategies
    62 3 Journal of Molecular S-C M Wang et al. Epigenetic PRMT signalling in 62:3 R223–R237 Endocrinology breast cancer REVIEW Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies Shu-Ching M Wang, Dennis H Dowhan and George E O Muscat Cell Biology and Molecular Medicine Division, The University of Queensland, Institute for Molecular Bioscience, St Lucia, Australia Correspondence should be addressed to S-C M Wang or G E O Muscat: [email protected] or [email protected] Abstract Breast cancer is a heterogeneous disease, and the complexity of breast carcinogenesis Key Words is associated with epigenetic modification. There are several major classes of epigenetic f breast cancer enzymes that regulate chromatin activity. This review will focus on the nine mammalian f epigenetic signalling protein arginine methyltransferases (PRMTs) and the dysregulation of PRMT expression f protein arginine and function in breast cancer. This class of enzymes catalyse the mono- and (symmetric methyltransferases and asymmetric) di-methylation of arginine residues on histone and non-histone target f arginine methylation proteins. PRMT signalling (and R methylation) drives cellular proliferation, cell invasion and metastasis, targeting (i) nuclear hormone receptor signalling, (ii) tumour suppressors, (iii) TGF-β and EMT signalling and (iv) alternative splicing and DNA/chromatin stability, influencing the clinical and survival outcomes in breast cancer. Emerging reports suggest that PRMTs are also implicated in the development of drug/endocrine resistance providing another prospective avenue for the treatment of hormone resistance and associated metastasis. The complexity of PRMT signalling is further underscored by the degree of alternative splicing and the scope of variant isoforms (with distinct properties) within each PRMT family member.
    [Show full text]
  • Genetic and Pharmacological Approaches to Preventing Neurodegeneration
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2012 Genetic and Pharmacological Approaches to Preventing Neurodegeneration Marco Boccitto University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Neuroscience and Neurobiology Commons Recommended Citation Boccitto, Marco, "Genetic and Pharmacological Approaches to Preventing Neurodegeneration" (2012). Publicly Accessible Penn Dissertations. 494. https://repository.upenn.edu/edissertations/494 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/494 For more information, please contact [email protected]. Genetic and Pharmacological Approaches to Preventing Neurodegeneration Abstract The Insulin/Insulin-like Growth Factor 1 Signaling (IIS) pathway was first identified as a major modifier of aging in C.elegans. It has since become clear that the ability of this pathway to modify aging is phylogenetically conserved. Aging is a major risk factor for a variety of neurodegenerative diseases including the motor neuron disease, Amyotrophic Lateral Sclerosis (ALS). This raises the possibility that the IIS pathway might have therapeutic potential to modify the disease progression of ALS. In a C. elegans model of ALS we found that decreased IIS had a beneficial effect on ALS pathology in this model. This beneficial effect was dependent on activation of the transcription factor daf-16. To further validate IIS as a potential therapeutic target for treatment of ALS, manipulations of IIS in mammalian cells were investigated for neuroprotective activity. Genetic manipulations that increase the activity of the mammalian ortholog of daf-16, FOXO3, were found to be neuroprotective in a series of in vitro models of ALS toxicity.
    [Show full text]
  • The Two Tort Dit U Nonton Un Mountin
    THETWO TORT DIT USU 20180010132A1NONTONUN MOUNTIN ( 19) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 / 0010132 A1 MAVRAKIS et al. ( 43 ) Pub . Date : Jan . 11 , 2018 ( 54 ) INHIBITION OF PRMT5 TO TREAT Publication Classification MTAP - DEFICIENCY- RELATED DISEASES (51 ) Int . CI. C12N 15 / 113 ( 2010 .01 ) (71 ) Applicant : NOVARTIS AG , Basel (CH ) A61K 45 / 06 ( 2006 . 01) ( 72 ) Inventors : Konstantinos John MAVRAKIS , A61K 31 / 7088 (2006 . 01 ) Boston , MA (US ) ; Earl Robert COZK 16 / 40 ( 2006 .01 ) MCDONALD , III , Wayland , MA (US ) ; A61K 39 /395 ( 2006 . 01 ) Frank Peter STEGMEIER , Acton , GOIN 33 /574 (2006 . 01 ) A61K 39 / 00 ( 2006 .01 ) MA (US ) (52 ) U . S . CI. CPC . .. C12N 15 / 1137 ( 2013 .01 ) ; A61K 39 /3955 ( 73 ) Assignee : Novartis AG , Basel (CH ) ( 2013 .01 ) ; A61K 45 / 06 ( 2013 .01 ) ; GOIN 33 /574 ( 2013. 01 ) ; C12Y 201/ 01 (2013 .01 ) ; ( 21 ) Appl. No. : 15 /510 , 542 A61K 31 /7088 (2013 .01 ) ; CO7K 16 / 40 ( 2013 .01 ) ; A61K 2039 /505 (2013 . 01 ) ; C12N ( 22 ) PCT Filed : Sep . 9 , 2015 2310 / 14 (2013 . 01 ) ; C12N 2320 / 31 ( 2013 .01 ) ; ( 86 ) PCT No .: PCT/ IB2015 /056902 CO7K 2317/ 76 ( 2013 .01 ) $ 371 (c ) ( 1 ) , (57 ) ABSTRACT ( 2 ) Date : Mar. 10 , 2017 The invention provides novel personalized therapies , kits , transmittable forms of information and methods for use in treating patients having cancer , wherein the cancer is Related U . S . Application Data MTAP - deficient and / or MTA -accumulating and thus ame (60 ) Provisional application No . 62/ 131 ,437 , filed on Mar . nable to therapeutic treatment with a PRMT5 inhibitor. Kits , 11 , 2015 , provisional application No .
    [Show full text]
  • The Protein Arginine Methyltransferase PRMT5 Regulates Proliferation
    The Protein Arginine Methyltransferase PRMT5 Regulates Proliferation and the Expression of MITF and p27Kip1 in Human Melanoma DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University by Courtney Nicholas Graduate Program in Molecular, Cellular, and Developmental Biology The Ohio State University 2012 Dissertation Committee: Gregory B. Lesinski, PhD, Advisor Jiayuh Lin, PhD Amanda E. Toland, PhD Susheela Tridandapani, PhD Copyright by Courtney Nicholas 2012 Abstract The protein arginine methyltransferase-5 (PRMT5) enzyme is a Type II arginine methyltransferase that can regulate a variety of cellular functions. We hypothesized that PRMT5 plays a unique role in regulating the growth of human melanoma cells. Immunohistochemical analysis indicated significant upregulation of PRMT5 in human melanocytic nevi (88% of specimens positive for PRMT5), malignant melanomas (90% positive) and metastatic melanomas (88% positive) as compared to normal epidermis (5% of specimens positive for PRMT5; p<0.001, Fisher’s exact test). Furthermore, nuclear PRMT5 was significantly decreased in metastatic melanomas as compared to primary cutaneous melanomas (p<0.001, Wilcoxon rank sum test). Human metastatic melanoma cell lines in culture expressed PRMT5 predominantly in the cytoplasm. PRMT5 was found to be associated with its enzymatic cofactor Mep50, but not associated with STAT3 or cyclin D1. However, histologic examination of tumor xenografts from athymic mice revealed a heterogeneous pattern of nuclear and cytoplasmic PRMT5 expression. siRNA-mediated depletion of PRMT5 inhibited proliferation in a subset of melanoma cell lines, while it accelerated the growth of others. Loss of PRMT5 also led to reduced expression of MITF (microphthalmia-associated transcription factor), a melanocyte-lineage specific oncogene, and increased expression of the cell cycle regulator p27Kip1.
    [Show full text]
  • ATP Is Required for Interactions Between UAP56 and Two Conserved Mrna Export Proteins, Aly and CIP29, to Assemble the TREX Complex
    ATP is required for interactions between UAP56 and two conserved mRNA export proteins, Aly and CIP29, to assemble the TREX complex Kobina Dufu,1 Michaela J. Livingstone,2 Jan Seebacher,1 Steven P. Gygi,1 Stuart A. Wilson,2 and Robin Reed1,3 1Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA; 2Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield S10 2TN, United Kingdom The conserved TREX mRNA export complex is known to contain UAP56, Aly, Tex1, and the THO complex. Here, we carried out proteomic analysis of immunopurified human TREX complex and identified the protein CIP29 as the only new component with a clear yeast relative (known as Tho1). Tho1 is known to function in mRNA export, and we provide evidence that CIP29 likewise functions in this process. Like the known TREX components, a portion of CIP29 localizes in nuclear speckle domains, and its efficient recruitment to mRNA is both splicing- and cap-dependent. We show that UAP56 mediates an ATP-dependent interaction between the THO complex and both CIP29 and Aly, indicating that TREX assembly is ATP-dependent. Using recombinant proteins expressed in Escherichia coli, we show that UAP56, Aly, and CIP29 form an ATP-dependent trimeric complex, and UAP56 bridges the interaction between CIP29 and Aly. We conclude that the interaction of two conserved export proteins, CIP29 and Aly, with UAP56 is strictly regulated by ATP during assembly of the TREX complex. [Keywords: CIP29; Aly; UAP56; TREX complex; Tho1; helicase] Supplemental material is available at http://www.genesdev.org. Received December 20, 2009; revised version accepted July 30, 2010.
    [Show full text]
  • Chromosome 21 Leading Edge Gene Set
    Chromosome 21 Leading Edge Gene Set Genes from chr21q22 that are part of the GSEA leading edge set identifying differences between trisomic and euploid samples. Multiple probe set IDs corresponding to a single gene symbol are combined as part of the GSEA analysis. Gene Symbol Probe Set IDs Gene Title 203865_s_at, 207999_s_at, 209979_at, adenosine deaminase, RNA-specific, B1 ADARB1 234539_at, 234799_at (RED1 homolog rat) UDP-Gal:betaGlcNAc beta 1,3- B3GALT5 206947_at galactosyltransferase, polypeptide 5 BACE2 217867_x_at, 222446_s_at beta-site APP-cleaving enzyme 2 1553227_s_at, 214820_at, 219280_at, 225446_at, 231860_at, 231960_at, bromodomain and WD repeat domain BRWD1 244622_at containing 1 C21orf121 240809_at chromosome 21 open reading frame 121 C21orf130 240068_at chromosome 21 open reading frame 130 C21orf22 1560881_a_at chromosome 21 open reading frame 22 C21orf29 1552570_at, 1555048_at_at, 1555049_at chromosome 21 open reading frame 29 C21orf33 202217_at, 210667_s_at chromosome 21 open reading frame 33 C21orf45 219004_s_at, 228597_at, 229671_s_at chromosome 21 open reading frame 45 C21orf51 1554430_at, 1554432_x_at, 228239_at chromosome 21 open reading frame 51 C21orf56 223360_at chromosome 21 open reading frame 56 C21orf59 218123_at, 244369_at chromosome 21 open reading frame 59 C21orf66 1555125_at, 218515_at, 221158_at chromosome 21 open reading frame 66 C21orf7 221211_s_at chromosome 21 open reading frame 7 C21orf77 220826_at chromosome 21 open reading frame 77 C21orf84 239968_at, 240589_at chromosome 21 open reading frame 84
    [Show full text]
  • HNRPUL1 (HNRNPUL1) Rabbit Polyclonal Antibody Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA345996 HNRPUL1 (HNRNPUL1) Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: IF, IHC, IP, WB Recommended Dilution: IF, IP, WB, IHC Reactivity: Human Host: Rabbit Isotype: IgG Clonality: Polyclonal Immunogen: The immunogen for anti-HNRPUL1 antibody: synthetic peptide directed towards the C terminal of human HNRPUL1. Synthetic peptide located within the following region: TYPQPSYNQYQQYAQQWNQYYQNQGQWPPYYGNYDYGSYSGNTQGGTSTQ Formulation: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. Note that this product is shipped as lyophilized powder to China customers. Purification: Protein A purified Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 83 kDa Gene Name: heterogeneous nuclear ribonucleoprotein U like 1 Database Link: NP_653333 Entrez Gene 11100 Human Q9BUJ2 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 4 HNRPUL1 (HNRNPUL1) Rabbit Polyclonal Antibody – TA345996 Background: HNRPUL1 is a nuclear RNA-binding protein of the heterogeneous nuclear ribonucleoprotein (hnRNP) family. This protein binds specifically to adenovirus E1B-55kDa oncoprotein. It may play an important role in nucleocytoplasmic RNA transport, and its function is modulated by E1B-55kDa in adenovirus-infected cells.This gene encodes a nuclear RNA-binding protein of the heterogeneous nuclear ribonucleoprotein (hnRNP) family.
    [Show full text]
  • S41598-021-85062-3.Pdf
    www.nature.com/scientificreports OPEN Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models Justin L. Tosh1,2, Elena R. Rhymes1, Paige Mumford3, Heather T. Whittaker1, Laura J. Pulford1, Sue J. Noy1, Karen Cleverley1, LonDownS Consortium*, Matthew C. Walker4, Victor L. J. Tybulewicz2,5, Rob C. Wykes4,6, Elizabeth M. C. Fisher1* & Frances K. Wiseman3* Individuals who have Down syndrome (caused by trisomy of chromosome 21), have a greatly elevated risk of early‑onset Alzheimer’s disease, in which amyloid‑β accumulates in the brain. Amyloid‑β is a product of the chromosome 21 gene APP (amyloid precursor protein) and the extra copy or ‘dose’ of APP is thought to be the cause of this early‑onset Alzheimer’s disease. However, other chromosome 21 genes likely modulate disease when in three‑copies in people with Down syndrome. Here we show that an extra copy of chromosome 21 genes, other than APP, infuences APP/Aβ biology. We crossed Down syndrome mouse models with partial trisomies, to an APP transgenic model and found that extra copies of subgroups of chromosome 21 gene(s) modulate amyloid‑β aggregation and APP transgene‑associated mortality, independently of changing amyloid precursor protein abundance. Thus, genes on chromosome 21, other than APP, likely modulate Alzheimer’s disease in people who have Down syndrome. Down syndrome (DS), which occurs in approximately 1 in 1000 births, is the most common cause of early-onset Alzheimer’s disease-dementia (AD-DS)1. Approximately 6 million people have DS world-wide and by the age of 65 two-thirds of these individuals will have a clinical dementia diagnosis.
    [Show full text]
  • HNRPUL1 (HNRNPUL1) (NM 007040) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC200576L3 HNRPUL1 (HNRNPUL1) (NM_007040) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: HNRPUL1 (HNRNPUL1) (NM_007040) Human Tagged ORF Clone Tag: Myc-DDK Symbol: HNRNPUL1 Synonyms: E1B-AP5; E1BAP5; HNRPUL1 Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC200576). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_007040 ORF Size: 2568 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 HNRPUL1 (HNRNPUL1) (NM_007040) Human Tagged ORF Clone – RC200576L3 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_007040.2 RefSeq Size: 3892 bp RefSeq ORF: 2571 bp Locus ID: 11100 UniProt ID: Q9BUJ2 Domains: SAP, SPRY Protein Families: Druggable Genome MW: 95.8 kDa Gene Summary: This gene encodes a nuclear RNA-binding protein of the heterogeneous nuclear ribonucleoprotein (hnRNP) family.
    [Show full text]